Neolys was born out of a common interest between industry and radiobiology researchers from Lyon, France to meet a particular need: predicting radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities. Neolys thus developed a reliable technology based on predictive tests, allowing for patient-specific treatments. Our solutions both optimize radiotherapy treatments efficiency and toxicity prevention. Neolys Diagnostics joined ALARA Group in late 2019.
| Website | https://neolys-diagnostics.fr/ |
| Employees | 6 (6 on RocketReach) |
| Founded | 2014 |
| Address | Centre Léon Bérard Bât. Cheney A, 28 Rue Laennec, Cedex 08, Lyon, Auvergne-Rhone-Alpes 69373, FR |
| Industry | Medical Practices, Membership Organizations, Biopharma, Organizations, Biotechnology, Health Care, Science and Engineering, Life Science, Medical |
| Keywords | Patient Specific Treatment, Precision Oncology, Predictive Diagnostics, Cancer Treatment Planning, Radiation Oncology, Oncology Diagnostics, Cancer Diagnostics, Personalized Medicine, Oncology Technology, Healthcare Technology, Clinical Diagnostics, Advanced Diagnostics, Medical Technology, Cancer Research |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, BD, Illumina, PerkinElmer, Inc., Abbott, Bio-Rad Laboratories, QIAGEN, Verily +41 more (view full list) |
| SIC | SIC Code 86 Companies |
Looking for a particular Neolys Diagnostics employee's phone or email?
6 people are employed at Neolys Diagnostics.
Neolys Diagnostics is based in Lyon, Auvergne-Rhone-Alpes.
The SIC codes for Neolys Diagnostics are [86].